Evidence map›Paper›PMID 31895811›Full record

Observational studyMedicine2020

Age-related changes in serum reproductive hormone levels and prevalence of androgen deficiency in Chinese community-dwelling middle-aged and aging men: Two cross-sectional studies in the same population.

Shan-Jie Zhou, Ming-Jia Zhao, Yi-Hong Yang, Di Guan, Zhi-Guang Li, Yu-Dang Ji, Bao-Long Zhang, Xue-Jun Shang, Cheng-Liang Xiong, Yi-Qun Gu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Shan-Jie ZhouReproductive Medicine Center, Department of Gynecology and Obstetrics, Peking University International Hospital, Beijing.
Ming-Jia ZhaoDepartment of Reproduction and Genetics, Maternity and Child Health Care Hospital of Tangshan, Tangshan.
Yi-Hong YangReproductive Medicine Centre, Department of Gynecology and Obstetrics, Key Laboratory of Ministry of Education on Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu.
Di GuanDepartment of Urology, Beijing Tongren Hospital, Capital Medical University, Beijing.
Zhi-Guang LiDepartment of Internal Medicine-Neurology, General Hospital of Jizhong Energy Xingtai Mining Group Co. Ltd., Xingtai.
Yu-Dang JiDepartment of Andrology, Fucheng Technical Service Center of Family Planning, Hengshui.
Bao-Long ZhangDepartment of Andrology, Fucheng Technical Service Center of Family Planning, Hengshui.
Xue-Jun ShangDepartment of Andrology, Nanjing General Hospital of Nanjing Military Command, PLA, Nanjing.
Cheng-Liang XiongReproductive Health Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan.
Yi-Qun GuNational Health and Family Planning Commission Key Laboratory of Male Reproductive Health, Department of Male Clinical Research, National Research Institute for Family Planning, Beijing, China.
Capital Medical University · CNHuazhong University of Science and Technology · CNNanjing General Hospital of Nanjing Military Command · CNPeking University · CNSichuan University · CNTangshan People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the age-related nomograms and change trends of reproductive hormones, and prevalence of androgen deficiency (AD) in middle-aged and aging men from 2 studies.Two cross-sectional studies were conducted at 5-year intervals in Chinese community-dwelling men living in the same area. A total of 434 (Study 1, S1) and 944 (Study 2, S2) men aged 40 to 69 years were recruited as subjects and 59 (S1) and 98 (S2) men aged 20 to 39 years as controls to measure serum reproductive hormone levels.Serum total testosterone (TT) levels did not change significantly in S1, whereas TT levels increased in S2 with aging. Serum calculated free testosterone (cFT) levels gradually decreased with aging; however, only men aged 40 to 69 years showed this trend in S2. Serum luteinizing hormone (LH) and sex hormone binding globulin (SHBG) levels gradually increased, and serum testosterone secretion index (TSI) and free testosterone index (FTI) levels gradually decreased with male aging. The mean annual decrease values of serum cFT were 2.705 pmol/l in S1 and 1.060 pmol/l in S2. The cut-off values for AD in S1 and S2 were 9.13 nmol/l and 9.35 nmol/l for TT, and 169.00 pmol/l and 213.90 pmol/l for cFT. Using TT or cFT cut-off values, mean AD prevalence was 14.52% or 44.70% in S1, and 6.36% or 16.53% in S2. Based on cFT cut-off values, prevalence of AD increased gradually with male aging in a range of 25.30% to 61.63% in S1 and 1.20% to 23.03% in S2.The change patterns of serum LH, SHBG, TSI and FTI levels in middle-aged and aging males were consistent; however, there were differences in serum TT and cFT change patterns in S1 and S2 with male aging. cFT cut-off values were the optimal metric to evaluate AD, which can be present a ladder-like change in prevalence of different age groups.

Indexed as

AdultAgedAgingChinaCross-Sectional StudiesEndocrine System DiseasesHumansLuteinizing HormoneMaleMiddle AgedNomogramsPrevalenceSex Hormone-Binding GlobulinTestosteroneYoung AdultLuteinizing HormoneSex Hormone-Binding GlobulinSHBG protein, humanTestosterone

Identifiers

PMID31895811
PMCPMC6946319
OpenAlexW2998712291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.